Retracted: Anticancer Activity of Mukonal Against Human Laryngeal Cancer Cells Involves Apoptosis, Cell Cycle Arrest, and Inhibition of PI3K/AKT and MEK/ERK Signalling Pathways
机构：[1]Department of Ear, Nose and Throat (ENT), Tongren Hospital of WuHan University (Wuhan Third Hospital), Wuhan, Hubei, China (mainland).[2]Department of Critical Care Medicine, Tongren Hospital of WuHan University (Wuhan Third Hospital), Wuhan, Hubei, China (mainland).
An editorial decision has been made to retract this manuscript due to breach of publishing guidelines, following the identification of non-original and manipulated figures. Reference: Liu Li, Lu Huizhi, Wang Binu, Deng Xinxin, Wu Longjun, Yang Liping, Zhang Yingying. Anticancer Activity of Mukonal Against Human Laryngeal Cancer Cells Involves Apoptosis, Cell Cycle Arrest, and Inhibition of PI3K/AKT and MEK/ERK Signalling Pathways. Med Sci Monit, 2018; 24: 7295-7302. DOI: 10.12659/MSM.910702.
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2021]版：
大类|4 区医学
小类|4 区医学：研究与实验
最新[2023]版：
大类|4 区医学
小类|4 区医学：研究与实验
第一作者：
第一作者机构：[1]Department of Ear, Nose and Throat (ENT), Tongren Hospital of WuHan University (Wuhan Third Hospital), Wuhan, Hubei, China (mainland).
通讯作者：
推荐引用方式(GB/T 7714)：
Li Liu,Huizhi Lu,Binu Wang,et al.Retracted: Anticancer Activity of Mukonal Against Human Laryngeal Cancer Cells Involves Apoptosis, Cell Cycle Arrest, and Inhibition of PI3K/AKT and MEK/ERK Signalling Pathways[J].Medical Science Monitor : International Medical Journal Of Experimental And Clinical Research.2022,28:e937840.doi:10.12659/MSM.937840.
APA：
Li Liu,Huizhi Lu,Binu Wang,Xinxin Deng,Longjun Wu...&Yingying Zhang.(2022).Retracted: Anticancer Activity of Mukonal Against Human Laryngeal Cancer Cells Involves Apoptosis, Cell Cycle Arrest, and Inhibition of PI3K/AKT and MEK/ERK Signalling Pathways.Medical Science Monitor : International Medical Journal Of Experimental And Clinical Research,28,
MLA：
Li Liu,et al."Retracted: Anticancer Activity of Mukonal Against Human Laryngeal Cancer Cells Involves Apoptosis, Cell Cycle Arrest, and Inhibition of PI3K/AKT and MEK/ERK Signalling Pathways".Medical Science Monitor : International Medical Journal Of Experimental And Clinical Research 28.(2022):e937840
